Loading Dose and Maintenance Dose Calculations

Calculating loading and maintenance doses is a core clinical pharmacokinetics skill required for safe prescribing of drugs with narrow therapeutic indices. The two calculations serve distinct pharmacokinetic purposes: the loading dose rapidly fills the volume of distribution to achieve a target concentration, while the maintenance dose replaces drug eliminated during each dosing interval to sustain that concentration at steady state.

The loading dose equation is: LD = (Vd × Cp,target) / F, where Vd is volume of distribution in litres, Cp,target is the desired plasma concentration, and F is bioavailability (1.0 for IV, <1 for oral). For digoxin with a Vd of 500 L (7 L/kg × 70 kg) and a target concentration of 1.0 µg/L given intravenously: LD = 500 L × 1.0 µg/L = 500 µg = 0.5 mg. However, oral digoxin bioavailability is approximately 0.63, so the oral loading dose would be 500/0.63 ≈ 794 µg ≈ 750–1000 µg given in divided doses to reduce toxicity risk. This two-step reasoning — calculate IV dose, then adjust for F — avoids common errors.

The maintenance dose equation is: MD = CL × Cp,target × τ / F, where CL is clearance, τ is the dosing interval. This can also be expressed as: MD = Cp,target × CL × τ / F, highlighting that maintenance dose is independent of Vd. Alternatively, the maintenance dose replaces drug eliminated each interval: MD = fraction eliminated per interval × amount in body = (1 − e^(-ke × τ)) × Vd × Cp,target / F. For steady-state IV infusion, the rate simplifies to: Rate = CL × Cp,target (no bioavailability needed as F=1 for IV).

The relationship between loading and maintenance doses illustrates why some drugs require dramatic adjustment in disease states. In renal failure with reduced digoxin clearance, the maintenance dose must be reduced proportionally to CL, while the loading dose (governed by Vd) is unchanged — unless fluid retention has also altered Vd. Similarly, in obesity, Vd for lipophilic drugs increases (requiring higher loading doses) while CL may not change proportionally (maintenance dose based on lean body weight for aminoglycosides).

Accumulation factor (R) quantifies how much drug accumulates at steady state compared to a single dose: R = 1 / (1 − e^(-ke × τ)) = 1 / (1 − fraction remaining per interval). At steady state, the average concentration is: CSS,avg = F × MD / (CL × τ). Peak and trough concentrations at steady state are: CSS,max = (F × MD / Vd) × (1 / (1 − e^(-ke × τ))) × e^(-ke × (τ − tlag)) and CSS,min = CSS,max × e^(-ke × τ), but for most clinical purposes, the average concentration equation suffices.

In NZ pharmacy practice, pharmacists frequently calculate vancomycin and aminoglycoside doses. For vancomycin, the target AUC/MIC ratio (AUC24 400–600 mg·h/L for S. aureus with MIC ≤ 1 mg/L) is now preferred over trough-only monitoring, per contemporary ASHP/SIDP/IDSA guidelines increasingly adopted by NZ hospital pharmacies. Renal function must be re-assessed at least daily for critically ill patients, with dose adjustment at each assessment.